U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499791) titled 'Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis' on Dec. 27, 2025.
Brief Summary: This study aims to evaluate the safety and effectiveness of an absorbable lacrimal sac drug-eluting stent placed at the osteotomy site during endoscopic endonasal dacryocystorhinostomy (E-DCR) in patients with recurrent chronic dacryocystitis. The stent is composed of absorbable polymer mesh coated with mometasone furoate to reduce postoperative inflammation and adhesion, maintain ostium patency, and improve surgical outcomes. A total of 40 patients will be randomized 1:1 to receive either the absorbable stent or conven...